Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Fablyn Increases Risk of Blood Clots: FDA Document
While the new osteoporosis drug Fablyn has been shown to be effective in postmenopausal women with...
-- Here are the latest clinical trials, courtesy of CenterWatch:
Melanoma
If you are 18 or older, have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, and have a life expectancy of greater than 12 weeks, you may qualify...
FRIDAY, Sept. 5 -- New research shows that obese people who have asthma are nearly five times more likely to be hospitalized for the problem and to have lower quality of life and worse control of the disease than those with asthma who are normal...
FRIDAY, Sept. 5 -- The last woolly mammoths had exclusively North American genetic roots, according to Canadian researchers who say their finding challenges conventional wisdom and could generate controversy.
Woolly mammoths lived between 40,000 and...
FRIDAY, Sept. 5 -- A new lung cancer risk assessment designed specifically for black Americans suggests that chronic obstructive pulmonary disease (COPD) is a much greater lung cancer risk factor for blacks than for whites.
Researchers at the...
Pharma Industry News
WASHINGTON, Sept. 2, 2008 - The House Committee on Energy and Commerce today posted on its website a letter sent to the CEOs of Schering-Plough and Merck & Co. over the SEAS study. The letter is...
THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Sep 4, 2008 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety...
PARIS, September 4, 2008 – The sanofi-aventis Central Anti-Counterfeit Laboratory was officially inaugurated today at the Tours pharmaceutical plant (in the Department of Indre-et-Loire, France) by Hervé Novelli, Minister of State to...
WINSTON-SALEM, N.C., Sept. 5, 2008– Free drug samples provided to physicians by pharmaceutical companies could actually be costing uninsured patients more in the long run, according to a study done by researchers at Wake Forest University...
WALTHAM, Mass.--(BUSINESS WIRE)--Sep 5, 2008 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Clarix LLC, an innovative provider...
New Drug Approvals
PRINCETON, New Jersey, September 3, 2008 -- Sandoz has received US Food and Drug Administration approval for its Omnitrope Pen 10 with liquid cartridge. Omnitrope, a somatropin, is approved for long-term treatment of pediatric patients who have...
WOODCLIFF LAKE, N.J., August 23, 2008 /PRNewswire/ -- Eisai Corporation of North America and its partner Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Aug 22, 2008 - Amgen Inc. (NASDAQ: AMGN) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nplate (romiplostim), the first and only platelet producer for the...
SUMMIT, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - Celgene Corporation today announced Vidaza (azacitidine) received expanded U.S. Food and Drug Administration (FDA) approval to reflect new overall survival achieved in the AZA-001 survival study of...
WASHINGTON, August 15, 2008 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Xenazine (tetrabenazine) for the treatment of chorea...
New Drug Applications
AUSTIN, Texas--(BUSINESS WIRE)--Sep 2, 2008 - Introgen Therapeutics, Inc., a developer of targeted molecular therapies for cancer, today announced that the United States Food and Drug Administration (FDA) notified the Company that its Biologics...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sep 2, 2008 - Alpharma Inc., a global specialty pharmaceutical company, today announced that the United States Food and Drug Administration ("FDA") has advised the Company that its New Drug Application ("NDA") for...
RALEIGH, N.C.--(BUSINESS WIRE)--Aug. 28, 2008 - BioDelivery Sciences International, Inc. (Nasdaq:BDSI) today announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug...
TITUSVILLE, N.J., August 26, 2008 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional data before it will approve the company's...
VANCOUVER and DEERFIELD, IL, August 11, 2008 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated August 8, 2008 from the...
Clinical Trials
The study will be presented today in advance of the American Society for Clinical Oncology Breast Cancer Symposium.
Approximately 30 percent of breast cancer cells have an excess amount of the HER2 protein on their surface, which makes the...
BETHESDA, Md., Sept. 4, 2008--The Cancer Genome Atlas (TCGA) Research Network, a collaborative effort funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH),...
Dr. Jason Slingsby, CEO of ProtAffin commented: “I am encouraged that the FDA has approved the Orphan Drug designation for PA401 for the prevention of delayed graft function after solid organ transplantation. This encouraging...
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
VIENNA, Va., September 05, 2008 /PRNewswire-FirstCall/ -- CEL-SCI Corporation announced today that it presented new rheumatoid arthritis data at the Marcus Evans conference on Immunogenicity in Amsterdam. The data, presented by Dr. Daniel Zimmerman,...
SAN MATEO, Calif., September 04, 2008 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER & Co. GmbH...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
